A Case of Lung Cancer: Postop Minimal Residual Disease at Pleura
For nonsmall cell lung cancer (NSCLC), surgery is indicated only for stage 3 as a curative measure. Even so, there is a high risk of recurrence following stage 3 lung cancer surgery, a third (33.9%) of patients experienced a cancer recurrence mostly within 2 years after surgery. The median surviv...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Aerospace Medical Association of Korea
2021-08-01
|
| Series: | Hanggong uju uihakoeji |
| Subjects: |